NEW YORK, Dec. 08, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Augmedix Inc. (NASDAQ: AUGX) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.
To view the full publication, “Latest Tech Key in Helping Solve Healthcare’s Largest Pain Point,” please visit: https://www.nnw.fm/HbxuB
Keeping up with precise documentation and a myriad of regulations is not only burdensome for physicians, it also restricts important physician/patient interaction and limits accurate and compassionate patient care. Many in healthcare believe it is the single largest pain point in the physician/patient relationship. The idea of outsourcing this task to third parties that have the resources and expertise to generate the requisite documentation much more cost effectively seems like a rational economic division of labor.
And make no mistake about it, technology is increasingly tipping the scale in favor of virtual documentation solutions with the latest advances in automatic speech recognition (ASR) and natural language processing (NLP). These technologies are integral to the virtual documentation solutions developed by Augmedix Inc. (NASDAQ: AUGX). A pioneer in virtual, real-time, medical-note documentation, Augmedix is “re-humanizing healthcare” and alleviating healthcare system pressures with its unique digital health platform that provides virtual medical documentation and live clinical support. The company is at the vanguard of the next generation of technologies being integrated into a healthcare marketplace that is notoriously cautious to make changes.
About Augmedix Inc.
Augmedix Inc., a leading provider of virtual medical documentation and live clinical support based in San Francisco, California, is on a mission to “rehumanize healthcare.” The company has set out to tackle the largest pain point in the U.S. healthcare system – the burden of documentation and administrative tasks on physicians.
For more information about the company, visit www.Augmedix.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.
NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…
MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…
SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free…
ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 04, 2024 (GLOBE NEWSWIRE) -- HUTCHMED…